FI990693A0 - Menetelmä luunmurtumien ennustamiseksi osteokalsiinimääritysten avulla - Google Patents

Menetelmä luunmurtumien ennustamiseksi osteokalsiinimääritysten avulla

Info

Publication number
FI990693A0
FI990693A0 FI990693A FI990693A FI990693A0 FI 990693 A0 FI990693 A0 FI 990693A0 FI 990693 A FI990693 A FI 990693A FI 990693 A FI990693 A FI 990693A FI 990693 A0 FI990693 A0 FI 990693A0
Authority
FI
Finland
Prior art keywords
coc
toc
mean
person
ioc
Prior art date
Application number
FI990693A
Other languages
English (en)
Swedish (sv)
Inventor
Sanna-Maria Kaekoenen
Heikki Luukinen
Kim Pettersson
Timo Loevgren
H Kalervo Vaeaenaenen
Original Assignee
Kaekoenen Sanna Maria
Heikki Luukinen
Kim Pettersson
Timo Loevgren
H Kalervo Vaeaenaenen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaekoenen Sanna Maria, Heikki Luukinen, Kim Pettersson, Timo Loevgren, H Kalervo Vaeaenaenen filed Critical Kaekoenen Sanna Maria
Priority to FI990693A priority Critical patent/FI990693A0/fi
Publication of FI990693A0 publication Critical patent/FI990693A0/fi
Priority to PCT/FI2000/000227 priority patent/WO2000058732A1/en
Priority to EP00914195A priority patent/EP1166122B1/en
Priority to ES00914195T priority patent/ES2320848T3/es
Priority to US09/937,620 priority patent/US6967081B1/en
Priority to DE60041534T priority patent/DE60041534D1/de
Priority to AT00914195T priority patent/ATE422672T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
FI990693A 1999-03-29 1999-03-29 Menetelmä luunmurtumien ennustamiseksi osteokalsiinimääritysten avulla FI990693A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI990693A FI990693A0 (fi) 1999-03-29 1999-03-29 Menetelmä luunmurtumien ennustamiseksi osteokalsiinimääritysten avulla
PCT/FI2000/000227 WO2000058732A1 (en) 1999-03-29 2000-03-20 Method for prediction of bone fractures by osteocalcin measurements
EP00914195A EP1166122B1 (en) 1999-03-29 2000-03-20 Method for prediction of bone fractures by osteocalcin measurements
ES00914195T ES2320848T3 (es) 1999-03-29 2000-03-20 Procedimiento para la prediccion de fracturas oseas mediante mediciones de osteocalcina.
US09/937,620 US6967081B1 (en) 1999-03-29 2000-03-20 Method for prediction of bone fractures by osteocalcin measurements
DE60041534T DE60041534D1 (de) 1999-03-29 2000-03-20 Verfahren zur vorhersage der wahrscheinlichkeit von knochenbrüchen mittels osteocalcin-messungen
AT00914195T ATE422672T1 (de) 1999-03-29 2000-03-20 Verfahren zur vorhersage der wahrscheinlichkeit von knochenbrüchen mittels osteocalcin-messungen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI990693A FI990693A0 (fi) 1999-03-29 1999-03-29 Menetelmä luunmurtumien ennustamiseksi osteokalsiinimääritysten avulla

Publications (1)

Publication Number Publication Date
FI990693A0 true FI990693A0 (fi) 1999-03-29

Family

ID=8554306

Family Applications (1)

Application Number Title Priority Date Filing Date
FI990693A FI990693A0 (fi) 1999-03-29 1999-03-29 Menetelmä luunmurtumien ennustamiseksi osteokalsiinimääritysten avulla

Country Status (7)

Country Link
US (1) US6967081B1 (fi)
EP (1) EP1166122B1 (fi)
AT (1) ATE422672T1 (fi)
DE (1) DE60041534D1 (fi)
ES (1) ES2320848T3 (fi)
FI (1) FI990693A0 (fi)
WO (1) WO2000058732A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259167A1 (en) * 1997-08-15 2004-12-23 Jukka Hellman Isolated osteocalcin fragments
EP1204871B1 (de) * 1999-08-14 2004-04-21 november Aktiengesellschaft Gesellschaft für Molekulare Medizin Verfahren zur indirekten bestimmung des blutgerinnungsstatus
GB0107393D0 (en) * 2001-03-23 2001-05-16 Osteometer Biotech As A method of assaying osteocalcin fragments in body fluids a test kit and means for carrying out the method and use of the method to monitor bone resorption
US9518976B2 (en) * 2006-09-13 2016-12-13 The Trustees Of Columbia University In The City Of New York Methods for identifying or assaying for agents that increase beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decrease fat mass
EP2326664A2 (en) * 2008-08-27 2011-06-01 Universidade Do Algarve A gammacarboxyglutamate-rich protein, methods and assays for its detection, purification and quantification and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0739439B2 (ja) 1989-03-16 1995-05-01 寳酒造株式会社 モノクローナル抗体及びその使用方法
EP0557663B1 (en) 1992-02-27 1997-05-02 Delmas, Pierre, Dr. Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin
FI973371A0 (fi) 1997-08-15 1997-08-15 Jukka Hellman Nya isolerade peptider

Also Published As

Publication number Publication date
EP1166122A1 (en) 2002-01-02
ES2320848T3 (es) 2009-05-29
ATE422672T1 (de) 2009-02-15
DE60041534D1 (de) 2009-03-26
WO2000058732A1 (en) 2000-10-05
EP1166122B1 (en) 2009-02-11
US6967081B1 (en) 2005-11-22

Similar Documents

Publication Publication Date Title
Alhava et al. The effect of drinking water fluoridation on the fluoride content, strength and mineral density of human bone
ATE423217T1 (de) Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten
HK1092219A1 (en) Method for detecting neoplastic disorders in a solubilized body sample
ATE403750T1 (de) Methoden und kompositionen zur bewertung von antikörper behandlungen
DK1469878T3 (da) FGFR agonister
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
NO20074515L (no) Fremgangsmate til prognose for mentale sykdommer, f.eks. autisme og cerebral parese
FI990693A0 (fi) Menetelmä luunmurtumien ennustamiseksi osteokalsiinimääritysten avulla
Rafique et al. Fluoride Levels in Urine, Blood Plasma and Serum of People Living in an Endemic Fluorosis Area in the Thar Desert, Pakistan.
ES2103906T3 (es) Evaluacion de la fragilidad osea y prediccion del riesgo de fracturas osteoporoticas utilizando una determinacion cuantitativa de osteocalcina subcarboxilada circulante.
Newaz et al. Uric acid, xanthine oxidase and other risk factors of hypertension in normotensive subjects
AU2002367317A8 (en) Psoriasin expression by breast epithelial cells
DE60217079D1 (de) Nachweis und quantifizierung von cripto-1
FR2831821B1 (fr) Marqueur biologique des etats de stress, procede d'evaluation quantitative de presence de ce marqueur, et son utilisation pour la prevention du stress
WO2005005957A3 (en) Method of detecting cancer using delta-catenin
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
ATE408827T1 (de) Quantifizierung von stressbelastung
ATE269356T1 (de) Mutierte gewebefaktor-inhibitor (tfpi), dna sequenz davon und verwendung zur erkennung von thrombotischen erkrankungen
BR0205443A (pt) Método de ensaio para fator de ativação de plaqueta
WO2005060627A3 (en) Methods of assessing the risk of non-traumatic bone fracture
DE602004022995D1 (de) Verfahren zur diagnose der immunität wiederkehrendren zur behandlung und überwachung
WO2003005033A8 (en) Carcinoma-related peptides
Winter et al. Preoperative antithrombin III activities and lipoprotein concentrations as predictors of venous thrombosis in patients with fracture of neck of femur.
DE60221151D1 (de) Verfahren zur bestimmung der prognose von krebspatienten mittels tucan
CN111337675A (zh) 一种骨质疏松筛查试剂盒